ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,230Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 35

$715K Total Retail Price of All Prescriptions

Rank: 13 out of 35

329 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 329 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

18% of this provider’s 329 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 9,830 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 33.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 460 453 1 3
OMEPRAZOLE 375 338 2 4
DONEPEZIL HCL 308 306 3 7
LISINOPRIL 297 280 4 5
SIMVASTATIN 279 267 5 6
FUROSEMIDE 274 267 6 1
NAMENDA 271 271 7 12
AMLODIPINE BESYLATE 263 259 8 9
HYDROCODONE-ACETAMINOPHEN 229 225 S3 9 2
SERTRALINE HCL 194 190 10 18
METOPROLOL SUCCINATE 187 187 11 20
METOPROLOL TARTRATE 185 175 12 11
CITALOPRAM HBR 183 181 13 13
QUETIAPINE FUMARATE 174 170 14 39
EXELON 171 171 15 59
WARFARIN SODIUM 146 145 16 8
POTASSIUM CHLORIDE 139 139 17 10
GABAPENTIN 135 125 18 14
ATORVASTATIN CALCIUM 123 117 19 28
POLYETHYLENE GLYCOL 3350 119 116 20 15
ALENDRONATE SODIUM 118 118 21 33
HYDROCHLOROTHIAZIDE 106 103 22 22
DIGOXIN 106 106 22 49
MIRTAZAPINE 93 90 24 16
SEROQUEL 93 91 24 103
ESCITALOPRAM OXALATE 90 89 26 30
GLIPIZIDE 88 84 27 68
METFORMIN HCL 85 79 28 19
DIVALPROEX SODIUM 84 84 29 21
SPIRIVA 84 84 29 61
LIDODERM 83 83 31 55
CYMBALTA 74 74 32 17
TAMSULOSIN HCL 68 64 33 29
AMOX TR-POTASSIUM CLAVULANATE 66 66 34 156
CARVEDILOL 65 58 35 25
LEVOFLOXACIN 61 55 36 75
FLUTICASONE PROPIONATE 60 60 37 62
GLIPIZIDE ER 60 60 37 101
CLOPIDOGREL 56 56 39 34
VOLTAREN 55 55 40 166
AZITHROMYCIN 54 38 41 57
PLAVIX 53 53 42 56
ATENOLOL 50 50 43 31
AGGRENOX 50 50 43 209
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.